Cell MedX Corp. | Income Statement
Fiscal year is June-May. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
42.60
36.60
6.20
1,556.30
Cost of Goods Sold (COGS) incl. D&A
-
-
28.50
49.00
127.10
-
Gross Income
-
-
14.10
12.50
120.90
-
SG&A Expense
12.60
18.50
957.40
2,091.80
1,101.20
1,556.30
EBIT
12.60
18.50
943.30
2,104.30
1,222.10
1,556.30
Unusual Expense
-
-
-
-
22.90
-
Non Operating Income/Expense
-
-
-
3.00
1.70
20.70
Interest Expense
-
-
88.90
37.90
52.00
11.20
Pretax Income
12.60
18.50
1,032.20
2,139.10
1,249.40
1,546.80
Consolidated Net Income
12.60
18.50
1,032.20
2,139.10
1,249.40
1,546.80
Net Income
12.60
18.50
1,032.20
2,139.10
1,249.40
1,546.80
Net Income After Extraordinaries
12.60
18.50
1,032.20
2,139.10
1,249.40
1,546.80
Net Income Available to Common
12.60
18.50
1,032.20
2,139.10
1,249.40
1,546.80
EPS (Basic)
0.00
0.00
0.03
0.07
0.03
0.04
Basic Shares Outstanding
31,000.00
31,000.00
31,000.00
31,000.00
36,859.70
42,311
EPS (Diluted)
0.00
0.00
0.03
0.07
0.03
0.04
Diluted Shares Outstanding
31,000.00
31,000.00
31,000.00
31,000.00
36,859.70
42,311
EBITDA
12.60
18.50
941.30
2,083.70
1,099.00
1,556.30
About Cell MedX
View Profile
